Detection of over 98% cystic fibrosis mutations in a Celtic population

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Nature Genetics

• Publication date

  1992-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/NG0692-188PMID 1284639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR).

  1992cited by this paper
• Molecular characterization of beta-thalassemia in the Sardinian population.

  1992cited by this paper
• Mutations of the cystic fibrosis gene locus within the population of the Northwest of England

  1992cited by this paper
• cAMP-inducible chloride conductance in mouse fibroblast lines stably expressing the human cystic fibrosis transmembrane conductance regulator.

  1991cited by this paper
• Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

  1991cited by this paper
• [Gene mutations of cystic fibrosis in Brittany population].

  1991cited by this paper
• Identification of novel rhodopsin mutations associated with retinitis pigmentosa by GC-clamped denaturing gradient gel electrophoresis.

  1991cited by this paper
• The search for south European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences.

  1991cited by this paper
• Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation

  1991cited by this paper
• Molecular characterization of mild-to-moderate hemophilia A: detection of the mutation in 25 of 29 patients by denaturing gradient gel electrophoresis.

  1991cited by this paper
• Screening for carriers of cystic fibrosis through primary health care services.

  1991cited by this paper
• Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy.

  1991cited by this paper
• Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium.

  1991cited by this paper
• Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

  1991cited by this paper
• A deletion of two nucleotides in exon 10 of the CFTR gene in a Soviet family with cystic fibrosis causing early infant death.

  1991cited by this paper
• Structural model of ATP-binding proteing associated with cystic fibrosis, multidrug resistance and bacterial transport

  1990cited by this paper
• A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein

  1990cited by this paper
• A frame-shift mutation in the cystic fibrosis gene

  1990cited by this paper
• The American Society of Human Genetics statement on cystic fibrosis screening.

  1990cited by this paper
• Carrier screening for cystic fibrosis.

  1990cited by this paper
• SIV grows unchanged in human cells

  1990cited by this paper
• Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

  1990cited by this paper
• Worldwide survey of the delta F508 mutation--report from the cystic fibrosis genetic analysis consortium.

  1990cited by this paper
• The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

  1990cited by this paper
• Three point mutations in the CFTR gene in French cystic fibrosis patients: Identification by denaturing gradient gel electrophoresis

  1990cited by this paper
• A 3′ splice site consensus sequence mutation in the cystic fibrosis gene

  1990cited by this paper
• Is population screening for cystic fibrosis appropriate now?

  1990cited by this paper
• Carrier screening for cystic fibrosis and other autosomal recessive diseases.

  1990cited by this paper
• CF screening

  1990cited by this paper
• Xerophthalmia and cystic fibrosis.

  1990cited by this paper
• CF screening delayed for awhile, perhaps forever.

  1990cited by this paper
• Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease.

  1990cited by this paper
• Benign missense variations in the cystic fibrosis gene.

  1990cited by this paper
• Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients.

  1990cited by this paper
• Carrier screening for cystic fibrosis and other autosomal recessive diseases.

  1990cited by this paper
• Population screening for cystic fibrosis.

  1990cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis.

  1989cited by this paper
• Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior.

  1989cited by this paper
• Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

  1989cited by this paper
• Identification of the cystic fibrosis gene: chromosome walking and jumping.

  1989cited by this paper
• The Metabolic basis of inherited disease

  1989cited by this paper
• Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

  1989cited by this paper
• Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes.

  1989cited by this paper
• A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia.

  1989cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus.

  1988cited by this paper
• Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations.

  1988cited by this paper
• Detection and localization of single base changes by denaturing gradient gel electrophoresis.

  1987cited by this paper
• Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis.

  1987cited by this paper
• Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes.

  1985cited by this paper
• Population screening for cystic fibrosis.

  1980cited by this paper
• Cluster of cystic fibrosis cases in a limited area of Brittany (France)

  1978cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper

• Reporting three rare pathogenic variants at the CFTR gene in two unrelated Iranian Azeri children with cystic fibrosis

  2024cites this paper
• Validation of the ACMG/AMP guidelines-based seven-category variant classification system

  2023cites this paper
• Increasing the Editing Efficiency of the MS2-ADAR System for Site-Directed RNA Editing

  2023cites this paper
• History and Classification of CRISPR/Cas System

  2022cites this paper
• La mucoviscidose

  2021cites this paper
• Cystic Fibrosis

  2021cites this paper
• [Cystic fibrosis: From gene discovery to precision medicine].

  2021cites this paper
• CRISPR-based RNA editing: diagnostic applications and therapeutic options

  2019cites this paper
• Was the Last Ice Age dusty climate instrumental in spreading of the three "Celtic" diseases (hemochromatosis, cystic fibrosis and palmar fibromatosis)?

  2019cites this paper
• Étude des paramètres nutritionnels des patients suivis au CRCM pédiatrique du CHU de Bordeaux dénutris ou à risque de dénutrition

  2018influential citation
• Site-directed RNA editing by adenosine deaminase acting on RNA for correction of the genetic code in gene therapy

  2017cites this paper
• ADN, recherches des mutations de la mucoviscidose

  2016cites this paper
• Highlighting the impact of cascade carrier testing in cystic fibrosis families.

  2016cites this paper
• Surface plasmon resonance based platforms for clinical and environmental biosensing applications

  2016cites this paper
• Label-free efficient and accurate detection of cystic fibrosis causing mutations using an azimuthally rotated GC-SPR platform.

  2014cites this paper
• Chapter 58 – Cystic Fibrosis

  2013cites this paper
• Mucoviscidose et conseil génétique

  2012cites this paper
• Génétique et gènes modificateurs, formes atypiques et rares

  2012cites this paper
• [Genetics and modifier genes, atypical and rare forms].

  2012cites this paper
• DETECCIÓN MOLECULAR DE TRES GRANDES DELECIONES DEL GEN CFTR EN PACIENTES FIBROQUÍSTICOS DE LA PROVINCIA DE BUENOS AIRES

  2011cites this paper
• Spectrum of CFTR Gene Mutations in Iranian Azeri Turkish Patients with Cystic Fibrosis

  2011influential citation
• scanning method for the analysis of the protein S active gene three polymorphisms in 19 patients with protein S deficiency using a Identification of 15 different candidate causal point mutations and

  2011cites this paper
• Temperature and Denaturing Gradient Gel Electrophoresis

  2010cites this paper
• CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR

  2010cites this paper
• CFTR allelic heterogeneity in Brazil: historical and geographical perspectives and implications for screening and counseling for cystic fibrosis in this country

  2010cites this paper
• eSensor®A Microarray Technology Based on Electrochemical Detection of Nucleic Acids and Its Application to Cystic Fibrosis Carrier Screening

  2009cites this paper
• CHAPTER 8 Temperature and Denaturing Gradient Gel Electrophoresis

  2009cites this paper
• Multiple Roles of Charged Amino Acids in Cytoplasmic Loop 7 for Expression and Function of the Multidrug and Organic Anion Transporter MRP1 (ABCC1)

  2009cites this paper
• Estimating the age of CFTR mutations predominantly found in Brittany (Western France).

  2008cites this paper
• Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

  2008cites this paper
• ADN, recherche des mutations de la mucoviscidose

  2008cites this paper
• Detection of two Alu insertions in the CFTR gene.

  2008cites this paper
• Cystic fibrosis in a southern Brazilian population: characteristics of 90% of the alleles

  2007cites this paper
• A Novel Donor Splice Site in Intron I I of the CFTR Gene, Created by Mutation

  2007cites this paper
• Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms

  2006cites this paper
• A new insertion/deletion of the cystic fibrosis transmembrane conductance regulator gene accounts for 3.4% of cystic fibrosis mutations in Sardinia: implications for population screening.

  2006cites this paper
• Invited Editorial: Cystic Fibrosis Genotypes and Views on Screening Are Both Heterogeneous and Population Related

  2006cites this paper
• Comprehensive Cystic Fibrosis Mutation Epidemiology and Haplotype Characterization in a Southern Italian Population

  2005cites this paper
• Review of denaturant capillary electrophoresis in DNA variation analysis

  2005cites this paper
• pic& Efficient9 and Sensitive Fibrosis tations

  2005cites this paper
• Genomic rearrangements in the CFTR gene: Extensive allelic heterogeneity and diverse mutational mechanisms

  2004cites this paper
• Genotype-phenotype relationship for five CFTR mutations frequently identified in western France.

  2004cites this paper
• Rapid Detection of 1078 delT Mutation by PCR-Mediated Sfte-Directed Mutagenesis : Detection of Cystic Fibrosis Canlers in a Celtic Population ,

  2004cites this paper
• Reproductive attitudes of couples having a child with cystic fibrosis in Brittany (France)

  2004cites this paper
• Comparison of the CFTR mutation spectrum in three cohorts of patients of Celtic origin from Brittany (France) and Ireland

  2003cites this paper
• Cystic fibrosis in Greece: molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high‐risk individuals

  2003cites this paper
• A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation?

  2003cites this paper
• Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France

  2003cites this paper
• Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients.

  2002cites this paper
• Cystic fibrosis: A worldwide analysis of CFTR mutations—correlation with incidence data and application to screening

  2002cites this paper
• A critical residue in the folding pathway of an integral membrane protein.

  2002cites this paper
• Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960

  2002cites this paper
• Relationship between genotype and phenotype for the CFTR gene W846X mutation

  2002cites this paper
• Prenatal detection of cystic fibrosis by ultrasonography: a retrospective study of more than 346 000 pregnancies

  2002cites this paper
• Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis

  2001cites this paper
• Génétique des pancréatites chroniques

  2001cites this paper
• Biosensor technology for real‐time detection of the cystic fibrosis W1282X mutation in CFTR

  2001cites this paper
• Frequency analysis and allele map in favor of the celtic origin of the C282Y mutation of hemochromatosis.

  2001cites this paper
• Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling

  2001cites this paper
• Cystic Fibrosis Mutation and Associated Haplotypes in Turkish Cystic Fibrosis Patients

  2001cites this paper
• Confirmation of the assignment of the Sanjad-Sakati (congenital hypoparathyroidism) syndrome (OMIM 241410) locus to chromosome lq42-43

  2000cites this paper
• Apport de la biologie moléculaire au dépistage néonatal de la mucoviscidose

  2000cites this paper
• Celtic Origin of the C282Y Mutation of Hemochromatosis

  2000cites this paper
• Mutation screening for prenatal and presymptomatic diagnosis: cystic fibrosis and haemochromatosis

  2000cites this paper
• Molecular Analysis in Brazilian Cystic Fibrosis Patients Reveals Five Novel Mutations

  2000cites this paper
• Distribution of CFTR gene mutations in cystic fibrosis patients from Estonia

  2000cites this paper
• Molecular analysis of 16 Turkish families with DHPR deficiency using denaturing gradient gel electrophoresis (DGGE)

  2000cites this paper
• Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis.

  2000cites this paper
• The incidence of cystic fibrosis (CF) mutations among patients from Croatia

  2000cites this paper
• Detection of the ΔF508 (F508del) mutation of the cystic fibrosis gene by surface plasmon resonance and biosensor technology

  1999cites this paper
• Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis

  1999cites this paper
• Risk of multisystem disease in isolated ocular angioma (haemangioblastoma)

  1999cites this paper
• Risk of multisystem disease in isolated ocular angioma (

  1999cites this paper
• Cystic Fibrosis Mutations: Report from the French Registry

  1999cites this paper
• Risk of multisystem disease in isolated ocular angioma (

  1999cites this paper
• hereditary and sporadic chronic pancreatitis ) gene in PSTI secretory trypsin inhibitor ( Mutational analysis of the human pancreatic

  1999cites this paper
• Risk of multisystem disease in isolated ocular angioma (

  1999cites this paper
• Risk of multisystem disease in isolated ocular angioma (haemangioblastoma)

  1999cites this paper
• Familial adenomatous polyposis (FAP) and its gene, APC

  1999influential citation
• Risk of multisystem disease in isolated ocular angioma (

  1999cites this paper
• Risk of multisystem disease in isolated ocular angioma (haemangioblastoma)

  1999cites this paper
• pancreatitis evidence for genetic heterogeneity in hereditary Mutations in the cationic trypsinogen gene and

  1999cites this paper
• Risk of multisystem disease in isolated ocular angioma (

  1999cites this paper
• Structure-Function Relationships

  1998cites this paper
• Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case.

  1998cites this paper
• Évaluation analytique et clinique du kit de détection des mutations du gène CFTR CF(12)m PCRTM

  1998cites this paper
• Relative frequencies of cystic fibrosis mutations in The Netherlands as an illustration of significant regional variation in a small country

  1998cites this paper
• Detection of more than 91% cystic fibrosis mutations in a sample of the population from Reunion Island and identification of two novel mutations (A309G, S1255L) and one novel polymorphism (L49L)

  1998cites this paper
• Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease.

  1998cites this paper
• Absence of mutations in the interspecies conserved regions of the CFTR promoter region in cystic fibrosis (CF) and CF related patients.

  1998cites this paper
• Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I)

  1998cites this paper
• Les bases moléculaires de la mucoviscidose en France : plus de 300 mutations et 506 génotypes différents sont en cause.

  1998cites this paper
• P67L: a cystic fibrosis allele with mild effects found at high frequency in the Scottish population.

  1998cites this paper
• The Second Half of the Cystic Fibrosis Transmembrane Conductance Regulator Forms a Functional Chloride Channel*

  1998cites this paper
• Cystic fibrosis in a Puerto Rican female homozygous for the R1066C mutation.

  1998cites this paper
• Screening for Cystic Fibrosis

  1998cites this paper
• Celtic origin of the C282Y mutation of hemochromatosis.

  1998cites this paper
• Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.

  1998cites this paper
• Phenylketonuria and the peoples of Northern Ireland

  1997cites this paper
• Factor VIII gene mutations found by a comparative study of SSCP, DGGE and CMC and their analysis on a molecular model of factor VIII protein

  1997cites this paper